Bernards R - Search Results

1

An antibiotic that mediates immune destruction of senescent cancer cells.

Casagrande Raffi G, Chen J, Feng X, Chen Z, Lieftink C, Deng S, Mo J, Zeng C, Steur M, Wang J, Bleijerveld OB, Hoekman L, van der Wel N, Wang F, Beijersbergen R, Zheng J, Bernards R, Wang L. Casagrande Raffi G, et al. Among authors: bernards r. Proc Natl Acad Sci U S A. 2024 Dec 24;121(52):e2417724121. doi: 10.1073/pnas.2417724121. Epub 2024 Dec 18. Proc Natl Acad Sci U S A. 2024. PMID: 39693343

2

Functional subtyping of breast cancer.

Beijersbergen RL, Bernards R. Beijersbergen RL, et al. Among authors: bernards r. Cancer Discov. 2011 Aug;1(3):205-6. doi: 10.1158/2159-8290.CD-11-0163. Cancer Discov. 2011. PMID: 22586571

3

High-Throughput Functional Genetic and Compound Screens Identify Targets for Senescence Induction in Cancer.

Wang L, Leite de Oliveira R, Wang C, Fernandes Neto JM, Mainardi S, Evers B, Lieftink C, Morris B, Jochems F, Willemsen L, Beijersbergen RL, Bernards R. Wang L, et al. Among authors: bernards r. Cell Rep. 2017 Oct 17;21(3):773-783. doi: 10.1016/j.celrep.2017.09.085. Cell Rep. 2017. PMID: 29045843 Free article.

4

PIM Kinases Are a Potential Prognostic Biomarker and Therapeutic Target in Neuroblastoma.

Brunen D, de Vries RC, Lieftink C, Beijersbergen RL, Bernards R. Brunen D, et al. Among authors: bernards r. Mol Cancer Ther. 2018 Apr;17(4):849-857. doi: 10.1158/1535-7163.MCT-17-0868. Epub 2018 Feb 13. Mol Cancer Ther. 2018. PMID: 29440296

5

Taking advantage of drug resistance, a new approach in the war on cancer.

Wang L, Bernards R. Wang L, et al. Among authors: bernards r. Front Med. 2018 Aug;12(4):490-495. doi: 10.1007/s11684-018-0647-7. Epub 2018 Jul 18. Front Med. 2018. PMID: 30022460

6

Identification of Autophagy-Related Genes as Targets for Senescence Induction Using a Customizable CRISPR-Based Suicide Switch Screen.

Schepers A, Jochems F, Lieftink C, Wang L, Pogacar Z, Leite de Oliveira R, De Conti G, Beijersbergen RL, Bernards R. Schepers A, et al. Among authors: bernards r. Mol Cancer Res. 2021 Oct;19(10):1613-1621. doi: 10.1158/1541-7786.MCR-21-0146. Epub 2021 Jun 22. Mol Cancer Res. 2021. PMID: 34158393 Free PMC article.

7

Exploiting senescence for the treatment of cancer.

Wang L, Lankhorst L, Bernards R. Wang L, et al. Among authors: bernards r. Nat Rev Cancer. 2022 Jun;22(6):340-355. doi: 10.1038/s41568-022-00450-9. Epub 2022 Mar 3. Nat Rev Cancer. 2022. PMID: 35241831 Review.

8

cFLIP suppression and DR5 activation sensitize senescent cancer cells to senolysis.

Wang L, Jin H, Jochems F, Wang S, Lieftink C, Martinez IM, De Conti G, Edwards F, de Oliveira RL, Schepers A, Zhou Y, Zheng J, Wu W, Zheng X, Yuan S, Ling J, Jastrzebski K, Santos Dias MD, Song JY, Celie PNH, Yagita H, Yao M, Zhou W, Beijersbergen RL, Qin W, Bernards R. Wang L, et al. Among authors: bernards r. Nat Cancer. 2022 Nov;3(11):1284-1299. doi: 10.1038/s43018-022-00462-2. Epub 2022 Nov 22. Nat Cancer. 2022. PMID: 36414711

9

Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins.

Beijersbergen RL, Bernards R. Beijersbergen RL, et al. Among authors: bernards r. Biochim Biophys Acta. 1996 Jun 7;1287(2-3):103-20. doi: 10.1016/0304-419x(96)00002-9. Biochim Biophys Acta. 1996. PMID: 8672526 Review.

10

Phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer.

Wang C, Jin H, Gao D, Lieftink C, Evers B, Jin G, Xue Z, Wang L, Beijersbergen RL, Qin W, Bernards R. Wang C, et al. Among authors: bernards r. J Hepatol. 2018 Nov;69(5):1057-1065. doi: 10.1016/j.jhep.2018.07.004. Epub 2018 Jul 18. J Hepatol. 2018. PMID: 30030148

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

338 results

Search Page

Filters